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Macrophages (Mo)t can use products of the respiratory burst to kill tumor cells
and microbial pathogens and to regulate the function;ofhost cells (1). In turn, each
class oftarget cells can regulate the capacity ofmacrophages to undergo a respira-
tory burst (2-11). Most studies of regulation of macrophage respiratory burst ca-
pacity have focussed on its enhancement (12). Much less is known about macro-
phage deactivating factors.
After culture with tumor cells, mouse peritoneal macrophages could no longer
undergo a respiratoryburst(13). Thephenomenon couldbereproduced with medium
conditioned by a wide variety of murine (6, 14) and human (15) tumor cells and
some nonmalignant cells (6). Macrophages' incubated in tumor cell-conditioned
medium (TCM) were markedly suppressed in their production of superoxide and
hydrogen peroxide in response to phorbol diesters, yeast cell walls, toxoplasma
trophozoites, or leishmania promastigotes (6, 7), in their killing oftoxoplasma and
leishmania (7, 16), and in their expression ofla antigens in response to rIFNy (17).
We use the term "MDF" to refer to the macrophage-deactivating factor(s) respon-
sible for the above effects.
Suppression ofthe respiratory burst inTCM-treated macrophageswas attributed
to the increased K oftheir superoxide-producing oxidase for NADPH (18). Sub-
sequently, TGF(31 and TGF02 were also found to suppress macrophage respira-
tory burst capacity (8). However, these cytokines did not increase the Km ofthe ox-
idase for NADPH, and antibodies that neutralized suppression ofthe respiratory
burst by TGF0 did not prevent suppression of the respiratory burst by MDF (19).
Recently, calcitonin gene-relatedpeptide (CGRP) (9) and IL-4 (10, 11) were reported
to suppress the respiratory burst capacity of monocytes.
Below we describe the purification from TCM of an acid-stable polypeptide of
-13 kD associated with potent MDF activity. This molecule appears to be distinct
from TGF-(3, CGRP, and IL-4.
Materials and Methods
BioassayforMDF .
￿
Activatedmacrophages(MO) were washed from theperitoneal cavities
offemale CDI mice (Charles RiverLaboratories, Wilmington, MA)with ctMEM (KC Bio-
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logicals, Lenexa, KS) 3-4 d after injection of 1 ml autoclaved sodium caseinate (practical
grade; Eastman Kodak Co., Rochester, NY) in normal saline, as described (20). The cells
were centrifuged (1,070 g, 10 min, 4°C) and resuspended in aMEM containing 10% heat-
inactivated horse serum (HyClone Laboratories, Logan, UT) with 100 U/ml penicillin and
100 kg/ml streptomycin. This medium will be referred to as M-10. 2 x 105 cells in 25 lil were
added to each well of 96-well plates (Costar Data Packaging, Cambridge, MA) containing
test samples and horse serum, such that the final volume was 135-150 td and the finalhorse
serum concentration was 10%. The cells were incubated overnight in 5% C02 at 37°C and
assayed for H202 release as described (20). In brief, the plates were washed in saline and
the adherent cells incubated in Krebs-Ringer phosphate buffer with glucose and 100 ng/ml
PMA as a trigger of the respiratory burst. The oxidation of the fluorescent indicator sco-
poletin by H202, catalyzed by horseradish peroxidase, was monitored fluorometrically for
45-90 min, the cell protein in the same wells was measured spectrophotometrically, and the
nmol H202 released per milligram adherent cell protein calculated as reported (20). A range
of volumes of MDFcontaining fractions was tested; the volume of test sample required for
50% inhibition of H202-releasing capacity was determined by interpolation and defined as
one unit. Units per milliliter of test sample were divided by milligrams of protein per mil-
liliter of test sample to give the specific activity of MDF. Specific activity is -, 10-fold higher
when macrophages are incubated in MDF for 48 rather than 24 h (6, 8); the shorter assay
was used for convenience.
7UM.
￿
P815 mouse mastocytoma cells (American Type Culture Collection, Rockville, MD)
were cultured at an initial density of 1.5 x 106/ml in a-MEM. After 48 h, the medium was
centrifuged (5,225 g, 30 min, 4°C) and the supernatant was sterilized by filtration (0.45 ju
Millex-HA; Millipore, Bedford, MA) and stored at 4°C.
Concentration ofMDFActivityfrom TCM .
￿
Three methods were used alternatively as indi-
cated in Results. (a) Solid ammonium sulfate was slowly added to TCM at 4°C with constant
stirring, maintaining the pH at 7.0 with NaOH until 70% saturation (wt/wt). The suspen-
sion was stirred for 4-6 h and the precipitate collected by centrifugation (12,100 g, 30 min,
4°C). The pellet was dissolved in 20 mM phosphate buffer pH 7.2 and dialyzed extensively
against the same and finally against PBS (Gibco Laboratories, Grand Island, NY). The di-
alysate was centrifuged (12,100g, 10 min, 4°C) and the supernatant filter-sterilized and stored
at -20°C. (b) TCM was concentrated by ultrafiltration on either YM-300, YM-100, YM-10,
or YM-5 membranes (Amicon Corp., Lexington, MA) under N2 at 4°C with slow stirring.
Filtrate and retentate were both reserved. (c) TCM was extracted with acid ethanol according
to the method of Roberts et al. (21) with minor modifications. Briefly, 1 vol TCM or the
retentate obtained upon ultrafiltration through YM100 or YM5 membranes was mixed over-
night at 4°C with 3 vol of 0.23 N HCl in 95% ethanol (in some experiments this contained
86 mg/liter ofPMSF). The acid-insoluble proteins were discarded aftercentrifugation (5,225
g, 10 min, 4°C) and the pH of the supernatant adjusted to 3-4 with ammonium hydroxide.
The acid-soluble proteins were further concentrated by the addition of 2 vol anhydrous ether
(Baker Laboratories, Phillipsburg, NJ) and 1 vol ethanol to 1 vol of supernatant. After 24 h
at -20°C, precipitated proteins were collected by centrifugation (5,225g, 20 min, 4°C) and
the supernatant discarded. The precipitate was dissolved in 1 M acetic acid and dialyzed
against the same overnight at 4°C . Insoluble material was discarded and the supernatant
lyophilized (Savant Instrument Co., Farmingdale, NY) and stored at -20°C.
Sephacryl5400 Chromatography.
￿
MDF concentrated by methods a or b was fractionated on
a 1.5 x 50 cm column of S-400 (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated
with PBS at 4°C at a flow rate of 10 ml/h. 4-ml fractions were collected and aliquots assayed
for MDF activity, protein content and polypeptide migration on SDS-PAGE. The same three
analyses were conducted on fractions from each ofthe following chromatographicprocedures.
Biogel P60Chromatography.
￿
Lyophilized MDF extracted by method c was dissolved in 1 M
acetic acid. The precipitate was removed by centrifugation and the supernatant was further
clarified by filtration (0.45 Pm) and applied on a 1.5 x 100 cm column ofBiogel P60 (Biorad
Laboratories, Richmond, CA) equilibrated with 1 M acetic acid at room temperature. 6-ml
fractions were eluted in 1 M acetic acid at a flow rate of 20 ml/h.SRIMAL AND NATHAN
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Ion-Exchange Chromatography.
￿
Active fractions from the Biogel P60 column were pooled,
dried, and reconstituted in 10 mM histidine HCl buffer, pH 6.0, containing 1 mM sodium
azide and 0.5 mM PMSF (buffer A) and applied on a Mono Q column (Pharmacia Fine
Chemicals, HR 5/5) equilibrated with buffer A flowing at 0.25 ml/min. Bound proteins were
eluted in 0.5 ml fractions over 30 min with a linear gradient of NaCl increasing to 1 M in
buffer A.
Reversed-Phase HPLC.
￿
MDF from the Mono Q step was applied to a 4.6 mm ID x 25
cm (5 Am pore) diphenyl RP column (Vydac, Hesparia, CA) equilibrated with 0.1% TFA
(Pierce Chemical Co., Rockford, IL) at a flow rate of 1 ml/min. Bound proteins were eluted
over 30 min in an increasing gradient of acetonitrile in 0.1% TFA. The elution profile was
monitored at 214 and 280 nm and 1-ml fractions were collected, dried, and reconstituted
in 0.1% TFA. The bioactive fraction was further purified by two sequential fractionations
on a RP C4 column (4.6 x 50 mm, 6.5 Am pore) (Synchrom, Lafayette, IN) equilibrated
with 0.1% TFA (phase A). Phase B was 100% acetonitrile in 0.1% TFA. Elution was moni-
tored at 214 and 280 nm and 1-ml fractions were collected.
Electrophoresis and Immunoblotting
￿
SDS-PAGE (15 x 17 x 0.08 cm gels) was carried out
by the method of Laemmli (22). The proteins were fixed in 30% methanol and 10% acetic
acid and visualized by silver staining with minor modifications of the method of Morrissey
(23). For immunoblots, the unfixed proteins, including pure porcine platelet TGF01 (R &
D Systems, Minneapolis, MN), pure recombinant human TGFal (a gift of M. Narachi;
Amgen, Inc., Thousand Oaks, CA), and pure rat CGRP (Peninsula Laboratories, Belmont,
CA) were transferred to nitrocellulose (0.22 pm, Schleicher & Schuell, Keene, NH) according
to the method of Towbin et al. (24) as modified (25). The transfer buffer contained 0.1%
SDS in 40 mM glycine, 25 mM Tris, 20% methanol pH 8.3 . After transfer, proteins were
visualized with amido black or Ponceau red and blocked overnight in blocking buffer (5%
nonfat dry milk in 20 mM Tris-buffered saline, pH 7.5 containing 0.2% Tween 20) at 4°C.
The blots were incubated with turkey antiTGF#, IgG, nonimmune turkey IgG (kind gifts
of M. Sporn; National Cancer Institute, Bethesda, MD), purified rabbit IgG antibody to
ubiquitin and ubiquitin-protein conjugates (a kind gift ofA. Haas; Medical College ofWis-
consin, Milwaukee, WI), a rabbit antiserum and a mouse mAb to retroviralp15E (kind gifts
of Dr. George Cianciolo, Duke University, Durham, NC), or nonimmune rabbit IgG for
2-3 h at 37°C. The blots were washed three times with blocking buffer and then incubated
in rabbit IgG anti-turkey IgG (Zymed Laboratories, San Francisco, CA) or goat IgG
anti-rabbit IgG (Boehringer Mannheim, Indianapolis, IN) coupled to alkaline phosphatase.
Immune complexes were visualized afterreaction with indolyl phosphate and nitroblue tetrazo-
lium (United States Biochemical Co., Cleveland, OH) in veronal acetate buffer pH 9.6.
Measurement of Protein Concentration.
￿
Protein was determined by the method of Lowry et
al. (26) with BSA as the standard. The concentration ofprotein in MDF fractions ofhighest
purity was determined by amino acid analysis afterhydrolysis in 6 N HCl (kindly performed
by M. O. McGinley and M. R Rohde; Amgen).
ControlofBacterial LPS Contamination.
￿
The water used to prepare all reagents was purified
by reverse osmosis and redistilled in glass shortly before use. Glassware was baked for 4 h
at 180°C. In some cases, LPS was removed from chromatographic columns by treatment
with 0.1 N NaOH (27). LPS, contamination of MDF fractions, culture media, and assay re-
agents was monitored by a chromogenic limulus amebocyte lysate assay (WhittakerMA Bio-
products, Walkersville, MD) with a sensitivity of -10 pg/ml. Test samples containing >0.3
ng/ml LPS were discarded.
Results
Distribution ofMDF in Both High and Low Mr Fractions of7LM.
￿
MDF was recov-
ered quantitatively in the supernatant after centrifugation ofTCM at 100,000 g (not
shown). This suggested that MDF was not comprised ofviruses or membrane vesicles
(28). MDF was only partially inactivated by 2:1 chloroform/methanol, and no ac-1350
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tivity was recovered in the organic phase (not shown), suggesting that a lipid did
not account forthe bioactivity. Association ofMDF with a restricted set ofproteins
was indicated by its quantitative recovery in the material remaining in solution in
40% ammonium sulfate but appearing in the precipitate at 70%. When MDF was
precipitated in 70% ammonium sulfate, redissolved, and fractionated on aSephacryl
S-400 column, activity eluted both in the void volume (Mr >450,000) and in late
fractions (Mr -12-25,000) (Fig. 1). MDFrich fractions from the void volume of5-
400 columns stained positively on SDS-PAGE by the Alcian blue method for pro-
teoglycansandnegatively charged glycoproteins (29). Likewise, ultrafiltration ofTCM
on membranes with nominal Mr cut-offs of 300,000 or 100,000 distributed MDF
almost equally to the retentates and filtrates (not shown). These observations sug-
gested that MDF might exist in TCM both as a low-Mr form and in association
with high-Mr glycoproteins or proteoglycans. We therefore sought a method to dis-
sociate MDF from other proteins.
Acid-Ethanol Extraction ofMDF.
￿
We took advantageofthe facts that MDF is stable
(18) under the acidic conditions used to activate latent TGFa (30) and that acid-
ethanolextractionand ether precipitation havebeen used topurify several cytokines,
includingTGF0(21). Theseprocedures concentrated MDFwith quantitative recovery
and a 24-fold increase in specific activity (Table I), far surpassing results with am-
monium sulfate precipitation or ultrafiltration (not shown).
Gel Filtration.
￿
When MDF had been extracted in acid-ethanol, precipitated in
ether, and dissolved in 1 M acetic acid, it consistently eluted from Biogel P60 in
a broad peak between ubiquitin (8,700 Mr) and chymotrypsinogen (25,000 Mr); oc-
casionally a minor portion of activity eluted with higher Mr materials (Fig. 2 A).
On SDS-PAGE under reducing conditions (Fig. 2 B), very few polypeptides were
demonstrable in the active fractions; species migrating below 14,000 Mr predomi-
nated. All active fractions also contained a species migrating at 66,000 Mr. Frac-
tions from the leading edge of the bioactive peak contained a 24,000 Mr species,
but this was much less abundant in the second halfofthe peak. Fractions that con-
tained large amounts ofthe 24,000 Mr species were devoid of MDF activity. No spe-
c
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FIGURE 1.
￿
Fractionation ofMDFon Sephacryl
S-400. The 70% ammonium sulfate precipitate
ofTCMwasredissolved anddialyzed againstPBS
and eluted from the column with PBS at 10
ml/min. 4-ml fractions were collected, from which
100 pl aliquots were tested, revealingMDFbio-
activity in the void volume as well as in low Mr
fractions. Arrows at the topmark the elutionof
ferritin,catalase, BSA, chymotrypsinogen, RNAse,
cytochrome c, and phenol red(Mr x 103 shown).
In this and subsequent figures, fraction 0
represents controlmedium; results aremeans ±
SEMfortriplicate wells in whichactivated mac-
rophages were incubatedwith test samplesfor24
h andwashed before H202 release wasmeasured
over 90 min after the addition of PMA, unless
otherwise indicated; where error bars are not
visible, they fall within the symbol.SRIMAL AND NATHAN
TABLE I
Summary of Purification of MDF
` Mean t SEM for number of batches of TCM shown in parentheses. Seven
batches were processed through gel filtration and three through RPHPLC.
Results are shown for fewer fractionations in cases where MDF activity was
not measured in enough doses to permit assignment of units, or protein was
not measured .
x With reference to TCM.
s Acid-ethanol extraction and ether precipitation.
l Biogel P60.
Mono Q.
"` Two fractionations in tandem.
I1 Corrected for estimated 50% albumin contamination.
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cies migrated differentially under reducingornonreducing conditions (not shown).
Despite theextensive purification afforded by this step, as evidenced by SDS-PAGE,
specific activity increasedonly4.6-fold (Table 1). This raised thepossibility that MDF
might be partially inactivated by fractionation, either bydenaturation orby separa-
tion from a cofactor. The concentration-response curve for the bioactive fractions
was not affected bytheaddition ofpooled inactive fractions(data not shown), militating
against the latter possibility.
Ion-Exchange Chromatography.
￿
Active fractions from the Biogel step were applied
to a Mono Q column. MDF activity was recovered in the flow-through and first
few includedfractions, while most ofthe contaminating species, includingalbumin,
were retained, alongwith unidentified materials that absorbed strongly at 254 nm
(Fig. 3) but not at 280 nm (not shown). This suggested that MDF was cationic at
pH 6. However, MDF could not be recovered from either of the cation exchange
columns tested (polyaspartate and sulfonic acid Synchropak, not shown). Despite
the eliminationofmost ofthe remaining protein, the MonoQfractionation afforded
only a 1.8-fold enrichment in specific activity. All the MDF activity applied to the
column was recovered. An activity that enhanced macrophage H202-releasing ca-
pacity was contained in the last two fractions from the Mono Q column whether
MDF was loaded (Fig. 3) or not (not shown), and thus represents an artefact .
RPHPLC
￿
MDF from the Mono Qstep eluted from a diphenyl RP column in
a single fraction at 54 ± 3% acetonitrile (Fig. 4 A). Analysis of this fraction on
a reduced Phastsystem minigel (Pharmacia) revealed a single band at 11-13,000 Mr
(Fig. 4B). However, alarge 10-25% gradient gel(seeMaterials and Methods) resolved
this fraction into fourbands, and revealed a fifth at 66,000 Mr(Fig. 4 C). The bands
in the 11,000-13,000 Mr region were electroblotted for gas-phase amino acid se-
quencing. Only three major sequences were obtained, corresponding to ubiquitin,
Stage Specific activity Recovery
Fold
purification
Ulmg protein' %i
TCM 9.4 t 0.8 (7) 100 1.0
Extracts 222 t 21 (4) 106 t 11 23.7
Gel filtrationl 1,008 t 174(4) 46 t 8 108
Anion exchangel 1,860(2) 45 198
RPHPLC (diphenyl) 6,060 (2) 14 647
RPHPLC (C4)" 57,534 t 3,318 (3)=t 2 6,1401352
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FIGURE 2 . Elution of MDF
from Biogel P60 . The starting
material was TCM that had
been extracted with acid-eth-
anol and precipitated in ether.
4-ml fractions were collected .
(A) Bioactivity . Arrows at the
top markthe elution offerritin,
bovine serum albumin, chymo-
trypsinogen, RNAse, and ubiq-
uitin (M, indicated in kDa). (B)
SDS-PAGE (silver-stained 10-
25% gradient gel run under
reducing conditions) of the in-
dicated fractions . Lanes marked
M, contained standards, as des-
ignated at the right (x 10-3 ) .
DF, dye front .
02-microglobulin, and a COOH-terminal fragment of albumin (Srimal, S., M.
McGinley,M. Rohde,M. Narachi, andC. Nathan, unpublished observations) . This
fractionation increased specific activity 3.3-fold, with recovery of 31% of the activity
loaded.
MDF from the diphenyl RPHPLC was fractionated twice by C4 RPHPLC . In
the first fractionation, bioactivity eluted in a single peak at 50 t 2% acetonitrile
(Fig . 5), while species absorbing at 280 and 214 nm eluted in multiple peaks (not
shown) . As revealed by SDS-PAGE, the first C4 fractionation separated the bioac-
tive species in the 13,000 M, range (fractions 49 and 50) from more abundant, in-
active species of similarM r (fractions 46-48, Fig . 5, inset) . In a second C4 fraction-
ation, the single peak of bioactivity (Fig . 6 A) corresponded to the sole absorbanceSRIMAL AND NATHAN
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FIGURE 3.
￿
Elution ofMDF from
Mono Q anion-exchange column.
0.06
￿
The bioactive material from the
Biogel P60 fractionation shown in
Fig. 2 was lyophilized and recon-
stituted in 2 ml 10mM histidine pH
0
￿
6. 500 141 was applied to the anion-
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￿
exchange column and eluted at 0.25
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ml/min in 10 mM histidine pH 6.
From the time marked by the
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￿
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￿
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￿
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peak (Fig. 6 B). Silver-stained SDS-PAGE revealed one band (sometimes appearing
as a doublet) at -13,000 Mr in the midst of a diffuse, faintly stained zone (Fig. 6
C). The tandem C4 fractionations increased the specific activity of MDF 9.5-fold
and permitted recovery of 14% of the activity loaded, with a yield of -1 Ftg pro-
tein/100 ml starting material.
The purification sequence described above was completed with three batches of
TCM. Two preparations contained a band at 66,000 M, whose intensity on silver
staining was closely comparable to that of the -13,000 M, band, even though the
66,000 M, band was barely visible in photographs (Fig. 6 C). In the third run, the
staining intensity of the 66,000 M, band was only -5% of that of the -13,000 M,
band. For both bands, the SDS-PAGE pattern was the same under reducing and
nonreducingconditions. Both bands and no additional species were revealed on SDS-
PAGE by autoradiography of the final product after iodination by the chloramine
T method. To detect carbohydrate, we oxidized the gel-bound proteins with perio-
date, coupled vicinal aldehydes to digoxigenin via a hydrazide linkage, and stained
with an alkaline phosphatase-conjugated antidigoxigenin mAb, using a commer-
cially available kit (Boehringer-Mannheim). The 66,000 M, band was visualized by
this method; the -13,000 M, band was not (gels not shown).
When 4 leg of the final bioactive fraction was placed directly in the sequenator,
one clearcut sequence was obtained, corresponding to the 20 NH2-terminal residues
of albumin. When 1.7 Ag of this preparation was subjected to SDS-PAGE and the
13,000 Mr region electroblotted to a polydivinylfluoride membrane, no sequence
could be obtained (Srimal, S., M. McGinley, M. Rohde, M. Narachi, and C. Na-
than, unpublished observations). Thus, MDF was contaminated with albumin, and
its own NH2 terminus appeared to be blocked.
Fractionation of Control Medium.
￿
Serum-containing M-10 medium in whichno tumor
cells had been grown was extracted with acid-ethanol, precipitated with ether, and
fractionated on Biogel P60 and diphenyl RPHPLC exactly as for MDE No MDF
activity could be detected (not shown) .1354
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FIGURE 4 . Fractionation of
MDFby RPHPLC . (A) Bioac-
tive material from the MonoQ
column was applied to a di-
phenyl RP column and eluted
at 1 ml/min with0.1°16TFAand
a linear gradient of 0-100%
acetonitrile as indicated by the
dashed line in the inset . 1-ml
fractions were collected, from
which 25-,l aliquots were as-
sayed . The bioactive fraction is
marked by an arrow on the ab-
sorbance profile (solid lint) in the
inset . (B) SDS-PAGE of bioac-
tive fraction (lane 2) on 9-25%
gradient Phastsystem Minigel
(Pharmacia Fine Chemicals,
0.43 x 0.5 x 0.04 cm) run
under reducing conditions and
stained with Coomassie blue.
The appearance was the same
when the gel was stained with
silver. (Lane 1) M, markers (x
10-3). (C) SDS-PAGE of bioac-
tive fraction (lane 3) andan in-
active fraction eluting onemin-
ute earlier (lane 2), usinga 15 x
17 x 0.08 cm 10-25% gel run
under reducing conditions and
stained with silver. (Lane 1) M,
markers (x 10 -3).
Immunoblotting andImmunoneutralization .
￿
Western blot with turkey antiTGF(3 an-
tibody 121 was positive when as little as 1 ng pure recombinant humanTGF01 was
subjected to SDS-PAGE and electrophoretic transfer to nitrocellulose. However, this
antibody failed to blot the protein transferred when 80 ng (4.6U in the 24-h assay)
ofMDFwas electrophoresed (not shown), suggestingTGF/3 wasnotpresent in excess
ofN1.3% . Since N15 pgTGFa1 constitutes 1 U in the 24-h bioassay forMDF (8),
0.09% contamination ofMDF with TGF01 could account for the observed bioac-
tivity and escape detection by Western blot . Accordingly, the most highly purified
MDF fraction was incubated in the fluid phase with 64 hg/ml ofantibody 121 . UnderSRIMAL AND NATHAN
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FIGURE 5.
￿
RPHPLC fractionation ofMDF on a C4 column, using the bioactive peak from
the diphenyl-C4 RPHPLC . (Main figure) Bioactivity profile . Aliquots of 25 pl were tested from
1-ml fractions. Thegap in the graph corresponds to fractions that were not tested . (Inset) Silver-
stained, reducing 9-20% SDS-PAGE ofindicated fractions. Note, only fractions 49 and 50 were
bioactive .M r standards are indicated (x 10-3).
these conditions, the H202 release-suppressing activity of 10 ng/ml authentic TGF
(31 was completely neutralized . However, the bioactivity of purified MDF was not
affected (Table II) . Likewise, polyclonal and monoclonal antibodies to P15E, avirus-
derived, monocyte-inhibitory peptide (4), did not inhibitMDF(not shown) . An an-
tibody that reacts with ubiquitin and ubiquitin-protein conjugates (31) immuno-
blotted a species within the MDFactive fraction from the diphenyl RPHPLC step,
but not longer reacted with MDF purified on the C4 column . Finally, an antibody
that Western-blotted ratCGRP (4,500 Mr) gave no signal with MDF, and authentic
rat CGRP lacked activity in the MDF assay (not shown) .
Discussion
MDFwas purified 6,140-fold from P815 cell-conditioned medium, yielding a single
peak on RPHPLC and a single major band on SDS-PAGE at "13,000Mr . No NH2-
terminal amino acid sequence could be obtained from this band in either the fluid
or solid phase, suggesting that theNH2 terminus ofMDFmay be blocked . Efforts
are underway to derive amino acid sequence from fragments ofMDE Proof that
the "13,000M r species is MDF will require the generation of antibodies and recom-
binant proteins corresponding to such sequences . Until this evidence is in hand,1356
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FIGURE 6 .
￿
Repeat RPHPLC fractionation ofMDF on a C4 column, using the bioactive peak
from the first C4 column. (A) Bioactivity profile, assayed as in legend to Fig . 5 . In both runs,
MDF eluted at 50 t 2% acetonitrile . (B) Elution profile at 1 ml/min, collecting 1-ml fractions
and monitoring absorbance at 214nm . The column was eluted with 0.1% TEA diluted with ace-
tonitrile to give the indicated percent acetonitrile at the end ofeach interval : 0-10 min,0% ; 11-39
min, 45% ; 40-49 min, 55% ; 50-65 min, 65% ; 66-70 min, 100%. The asterisk indicates an ab-
sorbance peak seen with buffer alone . The arrow marks the peak corresponding to MDF bioac-
tivity. (C) SDS-PAGE of 40 ng of protein from the bioactive peak .
it cannot be excluded thatMDF may be a molecule undetected by SDS-PAGE at
the present level of abundance .
The final preparations contained albuminin amounts varyingfrom N5°Io to -50%,
as identified by its migration on SDS-PAGE at 66,000M r and by its NH2-terminal
amino acid sequence. There appeared to be a high affinity betweenMDF and al-
bumin, such thatalbumin persistedthrough all seven steps, including three reversed-
phase separations, used to purifyMDF . We could only separateMDFfrom albumin
by elution from polyacrylamide gels . However, gel eluates caused artefacts in the
bioassay, andMDF activity could not be unequivocally demonstrated. The tendency
ofMDF to associate with higherMr proteins was also evident in the starting mate-
rial, which contained as much bioactivity in fractions of >450,000 M r as in frac-
tions of -12-25,000 M r . This is reminiscent of the behavior of several growth
factors . For example, TGFR forms noncovalent complexes both with the remnant
of its precursor and with a2-macroglobulin (32) . Alternatively, the bioactivity in
highMr fractions could have been due to aggregates ofMDF or to protein(s) other
than MDF .
PurifiedMDF afforded 50% inhibition of macrophage peroxide-releasing capacitySRIMAL AND NATHAN
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TABLE II
Inability of Anti-TGF-,B Antibody to Neutralize Purified MDF
' Macrophages were incubated in M10 alone or with the indicated cytokines
for 24 h, washed, and challenged with PMA.
: nmol/mg protein in 60 min (mean t SEM of triplicates).
S 3.5 ng/ml of pure TGF-S1 from porcine platelets.
II Purified by ammonium sulfate precipitation from turkey serum and included
in the bioassay at 40 jug/ml.
Purified turkey IgG no. 121, included in the bioassay at 64 lcg/ml, enough
to neutralize completely 10 ng/ml TGF-# in this assay.
"" Final preparation from second C4 column, diluted to 0.26 ng/ml to give partial
inhibition to increase the chance of neutralizing inhibitory activity.
at -10 nM (130 ng/ml) in the overnight assay used for most of the experiments,
or at -1 nM when the incubation with macrophages was extended to 48 h. This
potency is similar to that of several cytokines in bioassays that use primary, unse-
lected populations ofindicator cells, rather than clones oftransformed cells selected
for their sensitivity. Biogel P60 gel filtration and Mono Qanion exchange, the first
two chromatographic steps, eliminated the vast majority ofthe protein in TCM,
yet afforded disproportionately small increases in specific activity. This raises the
possibility that MDF may have been partly denatured as MDF was separated from
most of the higher Mr materials with which it was associated in TCM (Fig. 1). If
so, the specificactivity ofMDF in its native statemaybehigher thanafterpurification
by the methods used here.
Nonetheless, the fact that purified MDF was -1,000-fold less potent than pure
rTGF0l at suppressing macrophage peroxidase-releasing capacity(8) raised the pos-
sibilities that MDF may be TGF# or may act by inducing TGFa during the bio-
assay. TGF,3 was not detected at any stage of the purification. Specifically, we did
not observe a polypeptide migrating at 24,000 Mr under nonreducing conditions
and at 12,500 M, under reducing conditions; the NH2-terminal amino acid se-
quence of TGF~; a species reacting with antibody to TGF(3 on Western blot; or
most important, a bioactivity neutralizable with rabbit antiTGF0 antibody LC14-
/01 (19) orturkey antiTGF(3antibody 121. Antibody LC14-/31 neutralizesbothTGF01
and TGF02. Antibody 121 isspecificforTGF#1; turkey antibodiesspecific for TGFa2
also failed to inhibit MDF (not shown). All these antibodies completely neutralized
authentic TGFas when the antibodies were added directly to the MDF assay. Fi-
nally, TCM and TGF/3 appeared to suppress the macrophage respiratory burst by
distinct mechanisms (19). Production ofrecombinant MDFand antibodies to recom-
binant MDF or MDFencoded peptides will be necessary to exclude a contribution
Cytokine" Antibody H202 release:
_ _ 413 t 41
TGF-015 pre-immune Igll 93 t 7
immune IgGI 403 -t 10
_ _ 481 * 93
MDF"" - 333 t 22
pre-immune IgG 276 t 12
immune IgG 316 t 211358
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ofTGF/3. Determination ofthe MDF sequence will address the further possibility
that MDF may be a member of the TGF/3 superfamily (32).
MDF appears distinct from polypeptidesotherthan TGF(3 thathavebeen reported
to affect respiratory burst capacity of mononuclear phagocytes. M, distinguishes
MDF in its -13,000 M, form from «2-macroglobulin-protease complexes ("750,000
Mr) (33), although we cannot exclude a protease that acquires MDF activity upon
associating with a2-macroglobulin in the serum used for the bioassay. MDF appears
to be smaller than IL-4 (20,000 M,) (10, 11) and larger than CGRP (4,500 M,) (9).
Moreover, IL-4 (34) and CGRPwere inactive in ourMDF assay. In contrast to the
studies in which IL-4 and CGRP were found to suppress the respiratory burst, we
used tissue macrophages rather thanblood monocytes, andmurine rather than human
cells. We added IL-4 or CGRP after the cells were activated, rather than during
the activation process. These differences may account for the divergent findings.
TCM derived from P815 cells has served as the starting material for several at-
tempts to purify factors that suppress lymphocyte proliferation or antibody secre-
tion. Cornelius and Normann (35) reviewed these efforts, and noted thatthe findings
ofmost such studies areconsistent withtheir own evidence that the inhibitory mate-
rial is a lipid bound to proteins of>150,000 M,. Such factors are probably unrelated
to MDF.
Inour earlierwork, the lackoftoxicity ofTCM wasevident from both thereversi-
bility (6) and selectivity of its actions. Thus, there was no decrease in the ability
ofTCM-treatedmacrophages toadhere; phagocytize; secreteplasminogenactivator,
lysozyme, orarachidonate; catabolizehydrogen peroxide; ortake up glucose (6, 18).
Nor were TCM-treated macrophages deficient in their specific content or activity
of cytochrome b55s, NADPH, -ADP, catalase, glutathione, glutathione peroxidase,
glutathione disulfide reductase, myeloperoxidase, or protein kinase C, or in their
ability to translocate protein kinase C from a soluble to a particulate fraction (6,
18, 19). Likewise, in the presentstudy, suppression ofthe respiratory burst bypurified
MDF was not due to toxicity. The adherent cell protein content in wells containing
macrophagestreatedwith purified MDFwas no less than in controlwells, andMDF
treated macrophages appeared well spread by phase-contrast microscopy.
Purification ofMDF was not possible without the appreciation that traces ofLPS
can both induce (36) and block (3) macrophage activation. Several years of effort
were expended on chromatographic procedures that did not yield consistent results
until we monitored LPS routinely and excluded it rigorously.
Purification ofMDF will helpus learnifMDF shares any ofthe actions ofTGF0
(32)besides suppression ofthe macrophage respiratory burst.. Likewise, purification
ofMDF brings us closer totestingthe hypotheses that some nonmalignant cellsmay
contain MDF, and that MDF may play a role in regulating inflammation.
Summary
Macrophage deactivation factor (MDF) in P815 tumor cell-conditioned medium
was assayed by its suppression of the ability of activated mouse peritoneal macro-
phages to release hydrogen peroxide. MDF displayed properties ofa soluble pro-
tein(s) associated with both low (8-25,000) and high (>450,000) M r fractions. MDF
was purified 6,140-fold by a seven-step procedure: extraction withacid-ethanol; precipi-
tation with ether; and fractionation ongelfiltration, anion-exchange, diphenyl reversed-SRIMAL AND NATHAN
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phase and C4 reversed-phase HPLC columns, the last column twice. The final prep-
aration contained two species: (a) a -13,000 M, band on reducing or nonreducing
SDS-PAGE and on autoradiograms after radioiodination with chloramine T, and
(b) a 66,000 M, species ranging from -5% to -50% of the protein detectable by
silver stain. The 66,000 M, species was identified as albumin from its NH2-terminal
amino acid sequence. However, no amino acid sequence could be obtained for the
-13,000 M, species, either in fluid phase or after electroelution of the corresponding
SDS-PAGE band. Thus, -13,000 M, MDF associates tightly with albumin through
a variety of separation techniques, and may have a blocked NH2 terminus. Purified
MDF afforded 505 Io inhibition of activated macrophage H202 releasing capacity at
a concentration of 1-10 nM. Separation of MDF from most higher M, moieties was
associated with disproportionately small increases in specific activity, suggestingMDF
might be partially inactivated by purification. As purified, MDF was -1,000-fold
less potent at deactivating macrophages than TGF/3. Antibodies that neutralized
the macrophage-deactivating effect of TGFO did not inhibit deactivation by MDF
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